← All Sponsors
SPONSOR

Xuanwu Hospital, Beijing

Total Trials
17
Recruiting
17
Phases
Phase 4, Phase 3, Phase 1, Phase 2

Xuanwu Hospital, Beijing is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Mind-Body Therapies, Insomnia Chronic, Epilepsy, Super-refractory Status Epilepticus.

The trial portfolio spans Phase 4, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Xuanwu Hospital, Beijing

How many clinical trials has Xuanwu Hospital, Beijing sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Xuanwu Hospital, Beijing, of which 17 are actively recruiting participants. These trials cover conditions including Mind-Body Therapies, Insomnia Chronic, Epilepsy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xuanwu Hospital, Beijing research focus on?
Xuanwu Hospital, Beijing clinical trials span Mind-Body Therapies, Insomnia Chronic, Epilepsy, Super-refractory Status Epilepticus, Stroke, and additional conditions. The research pipeline includes Phase 4, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xuanwu Hospital, Beijing clinical trial?
To participate in a Xuanwu Hospital, Beijing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xuanwu Hospital, Beijing trials with current recruitment status updated daily.

Clinical Trials by Xuanwu Hospital, Beijing

NCT06969079
Recruiting

Ba Duan Jin for CI With Hyperarousal/Anxiety

Mind-Body Therapies
NCT06667232
Recruiting

Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG

Epilepsy
NCT07496749
Recruiting

KD Treatment for Super-refractory Status Epilepticus

Super-refractory Status Epilepticus
NCT07519044 Phase 4
Recruiting

Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion

Stroke
NCT06375759
Recruiting

Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia

Syringomyelia
NCT06394817
Recruiting

Beijing Disability Risk and Ageing Monitoring Study

Age Problem
NCT06658184
Recruiting

Effects of Sleep Restriction and Stimulus Control in Chronic Insomnia Patients

Chronic Insomnia
NCT06898151
Recruiting

Carotid Endarterectomy and Stenting Timing

Carotid Endarterectomy
NCT06863727
Recruiting

The Beijing Longitudinal Disability Survey in Community Elderly

Ageing
NCT07192029
Recruiting

Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery

Stroke
NCT06303414
Recruiting

Revascularization for Symptomatic Non-acute Carotid Artery Occlusion

Non-acute Carotid Artery Occlusion
NCT07566663
Recruiting

Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy

Postoperative Pain
NCT07253181 Phase 3
Recruiting

Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours

Acute Ischemic Stroke
NCT06598202 Phase 1, Phase 2
Recruiting

Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

Amyotrophic Lateral Sclerosis
NCT06779201
Recruiting

Fasting Effects on Metabolism and Immunity Study in Human

Fasting
NCT06782867
Recruiting

RNS for Treatment-resistant Obsessive-compulsive Disorder

Obsessive-Compulsive Disorder (OCD)
NCT07087873
Recruiting

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology